Expert NetworkExpert InterviewNRIX

Slingshot members are talking to an expert! The topic is:

Discussing current treatment options for CLL and the potential of Nurix Therapeutics' NX-5948, a BTK degrader

Executed on:Jul 12, 2024 10:00 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Mayo
  • Hematologist/oncologist and bone marrow transplant physician with a clinical focus on chronic lymphocytic leukemia, lymphoid malignancies, and rare histiocytic neoplasms
  • interested in incorporating various modalities of therapy that help serve individual patient needs, including using novel targeted therapies, bispecific T-cell engagers, and cellular therapy.
  • part of the bone marrow transplant and chimeric antigen receptor (CAR) T-cell therapy programs where he prescribes specialized treatments for patients with lymphoid malignancies.

Interview Goal

Discuss use of NX-5948 as a treatment for CLL

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.